|
| Press Releases |
|
 |
|
| Thursday, June 29, 2023 |
|
|
NanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun
|
| NanoViricides, Inc. (NYSE American:NNVC) (the "Company") reports that clinical trials of its broad-spectrum antiviral drug NV-CoV-2 began on June 17, 2023 with two oral drug products: (i) NV-CoV-2 Oral Syrup, and (ii) NV-CoV-2 Oral Gummies. more info >> |
|
| Monday, March 16, 2020 |
|
|
Coronavirus Drug Development Update from NanoViricides, Inc.
|
| NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, is providing an update on its efforts towards drug development for the current novel coronavirus SARS-CoV-2 that causes COVID-19. more info >> |
|
| Tuesday, March 17, 2020 |
|
|
NanoViricides公司冠狀病毒藥物開發更新
|
| NanoViricides公司（美國紐約證券交易所交易代碼NNVC）（公司）是基於新型納米藥學平台（公司）開發高效抗病毒治療方法的領先公司，目前正在為造成COVID-19的當前新型冠狀病毒SARS-CoV-2進行藥物開發，現提供其工作相關更新。 more info >> |
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
达势股份-達美樂中國收益和利潤雙雙增長 持續優化投資者結構
Oct 18, 2024 07:00 HKT/SGT
|
|
|
國泰君安國際再次簽署《好僱主約章》 營造和諧共融工作環境
Oct 17, 2024 19:30 HKT/SGT
|
|
|
田中貴金屬工業發表新產品半導體檢測設備用鈀合金材料「TK-SK」 
Oct 17, 2024 10:00 HKT/SGT
|
|
|
Athos宣佈其人工智慧生成的全新口服G9A抑製劑ATH-063的I期臨床試驗頂線數據，顯示其對強效抗炎調節性T細胞的選擇性擴增和啟動
Oct 17, 2024 08:00 HKT/SGT
|
|
|
香港董事學會的《施政報告》回應
Oct 16, 2024 21:38 HKT/SGT
|
|
|
泛遠國際附屬中標阿里巴巴國際站華東中心倉業務
Oct 16, 2024 17:18 HKT/SGT
|
|
|
復星已成功退出Ageas獲6.7億歐元
Oct 16, 2024 15:33 HKT/SGT
|
|
|
推動全球創新熱潮 廣發証券全力支持港青創業圓夢
Oct 15, 2024 14:28 HKT/SGT
|
|
|
減息週期展開 復星業務向好 股票及債券受惠
Oct 15, 2024 11:32 HKT/SGT
|
|
|
中國平安資產管理（香港）蟬聯中國保險資產管理業協會三項權威推介
Oct 15, 2024 09:14 HKT/SGT
|
|
|
應科院創新智慧出行科技 閃耀香港秋季電子產品展
Oct 14, 2024 21:26 HKT/SGT
|
|
|
金嗓子：高成長性持續兌現 長期回報股東凸顯投資價值
Oct 14, 2024 20:03 HKT/SGT
|
|
|
推動全球創新熱潮 廣發證券全力支持港青創業圓夢
Oct 14, 2024 17:32 HKT/SGT
|
|
|
泛遠國際附屬獲中國物流與採購聯合會評為「4A級物流企業」
Oct 14, 2024 10:59 HKT/SGT
|
|
|
秋電展與國際電子組件及生產技術展今日揭幕
Oct 13, 2024 17:28 HKT/SGT
|
|
|
|
| 更多新聞發布 >> |
|
|
|
|
|
